跳至主要内容
临床试验/NCT00431548
NCT00431548已完成不适用

Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV).

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2007年2月6日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Reactivity in retinal blood flow during 100% O2 breathing expressed as percent change

研究概览

简要总结

Ocular lesions, including cotton wool spots and retinal hemorrhage, are a common feature of HIV infection and acquired immunodeficiency syndrome (AIDS). The aetiology of these apparently vasoocclusive phenomena in HIV related retinopathy is not well understood. Several hypotheses including infectious damage of the retinal vasculature and altered retinal hemodynamics have been postulated. The latter would be compatible with the theory that the retina of HIV patients is hypoxic. However, direct measurement of oxygen tension in the retina is not possible and indirect methods have to be employed. The study objective was to investigate the reactivity in retinal blood flow to 100% oxygen breathing in patients with HIV.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Group 1 (Patients with HIV)
  • •Aged between 19 and 70 years, male and female
  • •HIV positive patients without HIV-related retinopathy with a CD4+ cell count  500 cells/mm3 stage A2, A3, B2, B3, C2 and C
  • •Best corrected visual acuity >= 0.8
  • •Ametropy < 6 dpt
  • •Group 2 (Healthy control subjects)
  • •Aged between 19 and 70 years
  • •Age and sex matched to the subjects in the HIV group (group matched)
  • •Matched with regard to the smoking habits in the HIV group
  • •Best corrected visual acuity >= 0.8
  • •Ametropy < 6 dpt

排除标准

  • •Evidence of any other eye disease
  • •Diabetes mellitus
  • •Systemic hypertension (defined as SBP > 150 mmHg or DBP > 90 mmHg)
  • •Abuse of illegal drugs

结局指标

主要结局

Reactivity in retinal blood flow during 100% O2 breathing expressed as percent change

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验